Medical News |
- Even one <i>CYP2C19</i> loss-of-function allele raises CV event risk post-PCI
- Idrabiotaparinux equals idraparinux in efficacy trial
- Cervical artery dissection recurrence rate higher than thought
- New genetic susceptibility loci for psoriasis identified
- Anti-coagulants reduce prostate-cancer specific death risk
- Anti-coagulants reduce prostate-cancer specific death risk
- Certain oral contraceptive formulations still linked to breast cancer risk
- Arterial properties useful in assessing CVD risk for FH and FCH patients
- Mechanism behind triglyceride-lowering effect of nicotinic acid revealed
- High intake of sugar sweetened drinks increases risk for Type 2 diabetes
- Pancreatic β-cells do not replicate after the age of 30 years
- Heat shock protein gene variant may double dilated cardiomyopathy risk
- Even one <i>CYP2C19</i> loss-of-function allele raises CV event risk post-PCI
- Certain oral contraceptive formulations still linked to breast cancer risk
| Even one <i>CYP2C19</i> loss-of-function allele raises CV event risk post-PCI Posted: 28 Oct 2010 05:00 PM PDT Results of a meta-analysis indicate that clopidogrel-treated patients undergoing percutaneous coronary intervention may have an increased risk for major adverse cardiovascular events if they carry one or more copies of the CYP2C19 loss-of-function allele. |
| Idrabiotaparinux equals idraparinux in efficacy trial Posted: 28 Oct 2010 05:00 PM PDT Idrabiotaparinux is as effective as its non-biotinylated analog idraparinux for the treatment of deep vein thrombosis, study findings indicate. |
| Cervical artery dissection recurrence rate higher than thought Posted: 28 Oct 2010 05:00 PM PDT Spontaneous cervical artery dissections recur in about a quarter of patients, reveals a long-term neurosonographic monitoring study. |
| New genetic susceptibility loci for psoriasis identified Posted: 28 Oct 2010 05:00 PM PDT Researchers have found new psoriasis susceptibility loci that could aid diagnosis of the condition and the development of new treatments. |
| Anti-coagulants reduce prostate-cancer specific death risk Posted: 28 Oct 2010 05:00 PM PDT Men with localized prostate cancer have a significantly reduced risk for dying from the disease if they are taking anticoagulants in addition to treatment with surgery or radiotherapy, report US researchers. |
| Anti-coagulants reduce prostate-cancer specific death risk Posted: 28 Oct 2010 05:00 PM PDT Men with localized prostate cancer have a significantly reduced risk for dying from the disease if they are taking anticoagulants in addition to treatment with surgery or radiotherapy, report US researchers. |
| Certain oral contraceptive formulations still linked to breast cancer risk Posted: 28 Oct 2010 05:00 PM PDT Current use of oral contraceptives is associated with a moderately increased risk for breast cancer, which is mainly attributed to levonorgestrel used in triphasic preparations, show results from the Nurses Health study II. |
| Arterial properties useful in assessing CVD risk for FH and FCH patients Posted: 28 Oct 2010 05:00 PM PDT Researchers say that measuring arterial wall thickness and function may be a useful tool in the management of patients with genetic dyslipidemias. |
| Mechanism behind triglyceride-lowering effect of nicotinic acid revealed Posted: 28 Oct 2010 05:00 PM PDT US researchers believe they have found a mechanism though which nicotinic acid achieves its therapeutic effect in lowering triglyceride levels. |
| High intake of sugar sweetened drinks increases risk for Type 2 diabetes Posted: 28 Oct 2010 05:00 PM PDT Results from a systematic review and meta-analysis show that individuals who drink 1-2 sugar sweetened beverages per day have a significantly greater risk for developing Type 2 diabetes or the metabolic syndrome than those who consume less than one per month. |
| Pancreatic β-cells do not replicate after the age of 30 years Posted: 28 Oct 2010 05:00 PM PDT US scientists have discovered that pancreatic β-cells do not naturally replicate after the age of 30 years. |
| Heat shock protein gene variant may double dilated cardiomyopathy risk Posted: 28 Oct 2010 05:00 PM PDT German researchers have identified a polymorphism of the heat shock protein gene HSPB7 that may double the risk for dilated cardiomyopathy among patients with no family history of the condition. |
| Even one <i>CYP2C19</i> loss-of-function allele raises CV event risk post-PCI Posted: 28 Oct 2010 05:00 PM PDT Results of a meta-analysis indicate that clopidogrel-treated patients undergoing percutaneous coronary intervention may have an increased risk for major adverse cardiovascular events if they carry one or more copies of the CYP2C19 loss-of-function allele. |
| Certain oral contraceptive formulations still linked to breast cancer risk Posted: 28 Oct 2010 05:00 PM PDT Current use of oral contraceptives is associated with a moderately increased risk for breast cancer, which is mainly attributed to levonorgestrel used in triphasic preparations, show results from the Nurses Health study II. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment